Systemic coagulation is activated in patients with meningioma and glioblastoma

[1]  S. Tucker,et al.  Imbalance in Coagulation/Fibrinolysis Inhibitors Resulting in Extravascular Thrombin Generation in Gliomas of Varying Levels of Malignancy , 2021, Biomolecules.

[2]  M. Caroli,et al.  Plasma levels of extracellular vesicles and the risk of post-operative pulmonary embolism in patients with primary brain tumors: a prospective study , 2021, Journal of Thrombosis and Thrombolysis.

[3]  M. Mandalà,et al.  Treatment of venous thromboembolism in cancer patients: The dark side of the moon. , 2021, Cancer treatment reviews.

[4]  Lara A. Kahale,et al.  American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. , 2021, Blood advances.

[5]  D. Altschul,et al.  The incidence of venous thromboembolism following surgical resection of intracranial and intraspinal meningioma. A systematic review and retrospective study , 2021, Clinical Neurology and Neurosurgery.

[6]  Baoguo Wang,et al.  Preoperative and intraoperative predictors of deep venous thrombosis in adult patients undergoing craniotomy for brain tumors: A Chinese single-center, retrospective study. , 2020, Thrombosis research.

[7]  J. Rak,et al.  Genetic and epigenetic regulation of cancer coagulome - lessons from heterogeneity of cancer cell populations. , 2020, Thrombosis research.

[8]  T. Gary,et al.  Incidence, Therapy, and Bleeding Risk—Cancer- Associated Thrombosis in Patients with Glioblastoma , 2020, Cancers.

[9]  A. Bhargav,et al.  Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature. , 2020, Journal of neurosurgery.

[10]  P. Wen,et al.  Thrombotic Complications in Gliomas , 2019, Seminars in Thrombosis and Hemostasis.

[11]  C. Ay,et al.  Venous Thromboembolism in Brain Tumors: Risk Factors, Molecular Mechanisms, and Clinical Challenges , 2019, Seminars in Thrombosis and Hemostasis.

[12]  M. Caroli,et al.  Significance and Prognostic Value of The Coagulation Profile in Patients with Glioblastoma: Implications for Personalized Therapy. , 2019, World neurosurgery.

[13]  D. Yılmaz,et al.  Immunohistochemical Evaluation of Hemostatic Changes in Glioblastoma Multiforme and Low-Grade Astrocytoma. , 2018, Turkish neurosurgery.

[14]  Georg Heinze,et al.  A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts. , 2018, The Lancet. Haematology.

[15]  A. Tjønneland,et al.  Impact of time since diagnosis and mortality rate on cancer‐associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort , 2018, Journal of thrombosis and haemostasis : JTH.

[16]  A. Khorana,et al.  Risk prediction of cancer-associated thrombosis: Appraising the first decade and developing the future. , 2018, Thrombosis research.

[17]  M. Caroli,et al.  Risk of post-operative venous thromboembolism in patients with meningioma , 2018, Journal of Neuro-Oncology.

[18]  A. Falanga,et al.  Mechanisms and risk factors of thrombosis in cancer. , 2017, Critical reviews in oncology/hematology.

[19]  D. Neuberg,et al.  Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin. , 2017, Blood.

[20]  A. Khorana,et al.  Predicting risk of venous thromboembolism in hospitalized cancer patients: Utility of a risk assessment tool , 2017, American journal of hematology.

[21]  M. Streiff.  Thrombosis in the setting of cancer. , 2016, Hematology. American Society of Hematology. Education Program.

[22]  C. Marosi,et al.  Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas. , 2014, Neuro-oncology.

[23]  F. Langer,et al.  Pathophysiology of Trousseau’s syndrome , 2014, Hämostaseologie.

[24]  A. Falanga,et al.  The coagulopathy of cancer , 2014, Current opinion in hematology.

[25]  C. Dirven,et al.  The incidence of postoperative thromboembolic complications following surgical resection of intracranial meningioma. A retrospective study of a large single center patient cohort , 2014, Clinical Neurology and Neurosurgery.

[26]  I. Pabinger,et al.  Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS). , 2014, Thrombosis research.

[27]  L. Held,et al.  Reduction of Thromboembolic Events in Meningioma Surgery: A Cohort Study of 724 Consecutive Patients , 2013, PloS one.

[28]  J. Rak,et al.  Brain Neoplasms and Coagulation , 2013, Seminars in Thrombosis & Hemostasis.

[29]  N. Mackman,et al.  Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. , 2013, Blood.

[30]  V. Vila,et al.  Circulating Endothelial Cells and Procoagulant Microparticles in Patients with Glioblastoma: Prognostic Value , 2013, PloS one.

[31]  R. Scienza,et al.  Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role , 2013, Thrombosis and Haemostasis.

[32]  C. Marosi,et al.  Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients. , 2013, Thrombosis research.

[33]  M. Donati,et al.  Thrombosis and cancer: 40 years of research. , 2012, Thrombosis research.

[34]  R. Scienza,et al.  Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles , 2011, Journal of Neuro-Oncology.

[35]  C. Marosi,et al.  Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  M. Berger,et al.  Risk factors for the development of serious medical complications after resection of meningiomas. Clinical article. , 2011, Journal of neurosurgery.

[37]  V. Vila,et al.  Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma , 2011, Journal of Neuro-Oncology.

[38]  M. Macey,et al.  Flow cytometric analysis of microparticle phenotype and their role in thrombin generation , 2011, Cytometry. Part B, Clinical cytometry.

[39]  H. Hemker,et al.  Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay. , 2010, Thrombosis research.

[40]  I. Pabinger,et al.  Tests predictive of thrombosis in cancer. , 2010, Thrombosis research.

[41]  D. Ornstein.  A Nickel's Worth of Cancer , 2008, Annals of Internal Medicine.

[42]  Gary H Lyman,et al.  Development and validation of a predictive model for chemotherapy-associated thrombosis. , 2008, Blood.

[43]  H. Chew,et al.  Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. , 2007, Journal of neurosurgery.

[44]  W. Ruf,et al.  Thrombin generation and the pathogenesis of cancer. , 2006, Seminars in thrombosis and hemostasis.

[45]  C. Fadul,et al.  Coagulation biology in glioma pathogenesis: a missing link? , 2005, Journal of thrombosis and haemostasis : JTH.

[46]  K. Meehan,et al.  The coagulation system as a target for the treatment of human gliomas. , 2002, Seminars in thrombosis and hemostasis.

[47]  W. Geerts,et al.  The risk of venous thromboembolism is increased throughout the course of malignant glioma , 2000, Cancer.

[48]  G. Gerotziafas,et al.  The Role of Tissue Factor in Cancer-Related Hypercoagulability, Tumor Growth, Angiogenesis and Metastasis and Future Therapeutic Strategies. , 2017, Critical reviews in oncogenesis.

[49]  P. Wen,et al.  Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials , 2017, Neuro-oncology.

[50]  M. Di Nisio,et al.  Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. , 2014, The Cochrane database of systematic reviews.

[51]  M. Berger,et al.  postoperative intracranial hemorrhage in patients with meningiomas , 2009 .

[52]  S. Béguin,et al.  The Thrombogram: Monitoring Thrombin Generation in Platelet Rich Plasma , 2000, Thrombosis and Haemostasis.